FENC (STOCKS)
Fennec Pharmaceuticals Inc. Common Stock
$12.060000
+0.230000 (+1.94%)
Prev close: $11.830000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeffrey S Hackman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $516.78M
- Employees
- 32
- P/E (TTM)
- -91.23
- P/B (TTM)
- 9.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $51.00M |
| Benefits Costs and Expenses | $33.37M |
| Costs And Expenses | $58.40M |
| Nonoperating Income/Loss | -$2.68M |
| Operating Expenses | $56.59M |
| Research and Development | $205.00K |
| Other Operating Expenses | $56.39M |
| Operating Income/Loss | -$5.59M |
| Income/Loss From Continuing Operations After Tax | -$8.38M |
| Income/Loss From Continuing Operations Before Tax | $4.83M |
| Net Income/Loss | -$8.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.28 |
| Diluted Earnings Per Share | -$0.28 |
| Basic Average Shares | 90,755,000 |
| Diluted Average Shares | 91,967,000 |
| Assets | $71.82M |
| Current Assets | $66.88M |
| Prepaid Expenses | $3.46M |
| Other Current Assets | $63.42M |
| Noncurrent Assets | $4.94M |
| Liabilities | $34.15M |
| Current Liabilities | $9.59M |
| Accounts Payable | $6.28M |
| Other Current Liabilities | $3.31M |
| Noncurrent Liabilities | $24.56M |
| Equity | $37.68M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $37.68M |
| Liabilities And Equity | $71.82M |
| Net Cash Flow From Operating Activities | -$5.78M |
| Net Cash Flow From Operating Activities, Continuing | -$5.78M |
| Net Cash Flow From Investing Activities | -$17.50M |
| Net Cash Flow From Investing Activities, Continuing | -$17.50M |
| Net Cash Flow From Financing Activities | $23.28M |
| Net Cash Flow From Financing Activities, Continuing | $23.28M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$8.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.38M |
| Other Comprehensive Income/Loss | $0.00 |